Clinical Trial: A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07333742) titled 'A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal' on Nov. 24, 2025.

Brief Summary: Bioequivalence study for the fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg under fed conditions in healthy volunteers

Study Start Date: Sept. 29, 2025

Study Type: INTERVENTIONAL

Condition: Fed Conditions Healthy Volunteer

Intervention: DRUG: Test drug: Fixed-dose combination (FDC) of gemigliptin/dapagliflozin/me...